Andree Amelsberg

Person

Danbury, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Quinazoline derivatives for the treatment of cancer diseases
- Patent number 9,539,258
- Issue date Jan 10, 2017
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazoline derivatives for the treatment of cancer diseases
- Patent number 9,089,571
- Issue date Jul 28, 2015
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazoline derivatives for the treatment of cancer diseases
- Patent number 8,404,697
- Issue date Mar 26, 2013
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20180360834
- Publication date Dec 20, 2018
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
- Publication number 20180086744
- Publication date Mar 29, 2018
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20170112835
- Publication date Apr 27, 2017
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20150272954
- Publication date Oct 1, 2015
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
- Publication number 20140199298
- Publication date Jul 17, 2014
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20130178487
- Publication date Jul 11, 2013
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
- Publication number 20090306101
- Publication date Dec 10, 2009
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20090306044
- Publication date Dec 10, 2009
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of alpha specific antibody BIBH1 in the treatment of cancer
- Publication number 20030103968
- Publication date Jun 5, 2003
- Andree Amelsberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Andree Amelsberg

Person

Patents Grantslast 30 patents

Quinazoline derivatives for the treatment of cancer diseases

Quinazoline derivatives for the treatment of cancer diseases

Quinazoline derivatives for the treatment of cancer diseases

Patents Applicationslast 30 patents

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

Use of alpha specific antibody BIBH1 in the treatment of cancer